The scientists here at Consumer Reports read Dr. Richard Raymond’s op-ed “Antibiotics and Animals Raised for Food: Lies, Damn Lies and Statistics” with great interest. We were particularly struck by his assertion that most antibiotics used in animal production are not used to treat humans and are therefore “not critical to your or my health.” This claim is not scientifically justifiable. While it is true that not all of the antibiotics used in food animal production are used in human medicine, a majority of them belong to the same drug “classes”. Antibiotics in the same class often work to stop the growth of bacteria by using a similar mechanism of action. This becomes important when you consider the scientific principles of cross-selection and co-selection. Cross-selection means that the gene for resistance to one antibiotic will often also confer resistance to other antibiotics in the same class that work by the same mechanism of action. So giving one antibiotic to an animal that may not be used in human medicine may lead to the development of a bacteria resistant to an antibiotic in the same class that is used in human medicine. For example, cepharin (first generation cephalosporin) is used to treat mastitis in cattle but not used in human medicine, while cephalexin (first generation cephalosporin) is used in human medicine to treat Staphylococcus aureus. Bacteria that become resistant to cepharin, due to overuse in cattle, will also be resistant to cephalexin. Interestingly, Dr. Raymond cites cephalosporin as an antibiotic critical to human health. Another important principle is co-selection, where multiple resistant genes can be transferred together, because they are physically located next to each other in the bacteria’s genetic material, either the main chromosome or extra-chromosomal DNA. This means that feeding a specific antibiotic to food animals that is not used in human medicine could actually lead to the development of bacteria that are resistant to other antibiotics in different classes that are important in human medicine. Yet despite these scientific principles, Dr. Raymond believes “that the majority of antibiotics used in animals are of little or no importance to me as a physician or a grandparent.” However, the basic point he misses is that bacterial species can readily swap resistance genes with each other and bacteria in other species, genera and even other families–hardly of “little or no importance.” That resistance is accelerated and amplified by feeding healthy animals low doses of antibiotics everyday. When it comes to antibiotics like tetracyclines, unlike Dr. Raymond, we agree with the World Health Organization that there is a benefit to guarding their effectiveness. Tetracyclines are used against infectious diseases, including chlamydia, typhus, syphilis, Lyme disease, Legionnaire’s disease, malaria, Rocky Mountain Spotted Fever, cholera and the bubonic plague. Bacterial resistance to tetracycline was identified as early as the 1950s, the FDA tried to ban the use of tetracycline for growth promotion purposes in animal production as far back as 1977, and in 1986, Sweden prohibited the use of antibiotics including tetracycline for growth-promotion purposes. All of Europe followed in 2006. In this country, however, we have continued to allow tetracycline and other antibiotics to be fed indiscriminately for growth promotion purposes to healthy animals everyday. It remains to be seen if FDA’s 2012 request to drug producers and the livestock industry to voluntarily phase out this use by 2015 will produce any real reduction in antibiotic use in food animals. Dr. Raymond spends a lot of time focusing on the amounts of antibiotics used in humans versus animals. The fact that the inappropriate use of antibiotics–regardless of whether or not they are used in humans or animals–leads to an acceleration of the development of antibiotic resistance is a scientific fact. We agree with Dr. Raymond that the overuse of antibiotics in human medicine is an important issue. But since the same science that applies to the overuse in humans also applies to animals, we can not understand why he does not see overuse of these important drugs in animals as a problem. As for the exact numbers of how many antibiotics are used in food animal production—that data isn’t well disclosed to the public and is the subject of much debate. Dr Raymond uses his own numbers of unknown (or not easily obtainable) origin, which introduces a lack of transparency in his analysis. This is why groups like Consumers Union, the policy and advocacy arm of Consumer Reports, are supporting legislation to make this information readily available to everyone. Finally to answer Dr. Raymond’s question: “So when you read a report funded by Consumers Union, stating that they found Salmonella sp. bacteria resistant to Cipro (a fluoroquinolone), where do you think that resistance came from?” The answer is not–as Dr Raymond implies– from the human use of Cipro. Salmonella is a bacteria found on chicken or pork and not normally on humans. Salmonella therefore will have only been marginally exposed to all those flouroquinolones used in humans, compared to the flouroquinolone use in animals. So, resistance to cipro found in Salmonella from pigs or chickens, is likely due to use of flouroquinolones in animal agriculture not human medicine. Flouroquinolones were approved for all uses in poultry production in 1996 but were banned in 2005 because resistance rates went up after use. As one of the few independent consumer organizations that has been regularly testing meat and poultry for pathogens and antibiotic resistance for fifteen years, we believe that the the routine daily administration of antibiotics to animals is dangerous for public health. The problems and consequences of amplifying antibiotic resistance from feeding healthy animals antibiotics everyday is hardly a “Lie” or a “Damn lie”—it is a serious problem—a problem that was not invented by consumer organizations. In fact, groups like WHO, FDA, CDC, the EU, and medical and public health communities have all acknowledged the importance of addressing this issue. Healthy people don’t eat antibiotics everyday and neither should animals. It’s time for the industry to stop making excuses and stop inappropriately using these medically important drugs. Truth and Transparency: Unlike Dr. Raymond, Consumer Reports accepts no money from the antibiotic industry or any industry for that matter. Since 1936, Consumer Reports has been singularly focused on the consumer interest and refuses advertising, free samples, and corporate contributions. It is supported by the sale of its products and services and donations from consumers and foundations.Urvashi Rangan, PhD is an environmental health scientist and toxicologist. She leads Consumer Reports’ Consumer Safety and Sustainability Group and serves as the Executive Director of its Food Safety and Sustainability Center. Dr. Rangan directs all of the organization’s scientific risk assessments related to food and product safety, which she translates into actionable recommendations for both lawmakers and consumers. Most recently, she was the architect of the organization’s studies of arsenic in apple juice and rice and is a national expert on labels. Michael K. Hansen, PhD is a Senior Scientist with Consumers Union, the policy and advocacy arm of Consumer Reports. He works primarily on food safety issues and has been largely responsible for developing the organization’s positions on the safety, testing and labeling of genetically engineered food and “mad cow” disease. Dr. Hansen served on the USDA Advisory Committee on Agricultural Biotechnology from 1998-2002, and on the California Department of Food and Agriculture Food Biotechnology Advisory Committee, from 2001-2002. Michael Crupain, MD, MPH is the Director of Consumer Reports’ Food Safety and Sustainability Center where he directs the day-to-day operations of the organization’s food-safety testing. He joined Consumer Reports in 2012 and is a trained physician in Preventive Medicine with expertise in public health-based risk assessment. Dr. Crupain received his Masters in Public Health from the Johns Hopkins School of Public Health, where he is also an adjunct professor.

  • Mike_Mychajlonka_PhD

    Dr. Raymond chose a rather combative, even belligerent, title for his recent opinion piece.  Despite this, he repeatedly chose not to engage on the core issues of a topic he, himself, raised.  In the discussion following the publication of his opinion piece, I suggested that he answer substantive questions put to him by another participant.  He never did so.  Nor did he ever speak to technical points I subsequently raised.  He threw out a challenge to the Pew Charitable Trust asking for an example of where an ionophore was ever shown to cause antibiotic resistance.  I promptly provided that discussion with a recent citation, which showed scientific proof that resistance to the ionophore Narasin co-selected for Vancomycin resistance in Enterbacter faecalis.  Again, no response was received.  I can’t help but wonder what his purpose was, or, to put the question in terms of an old, meat industry advertising jingle:  “Where’s the Beef?”

    • Oginikwe

       “. . . do some
      consulting on food safety and public health for Elanco, a marketer of
      antibiotics” That pretty much told me all I needed to know.

      • Richard Raymond

        Not only do I disclose any possible conflicts of interest, but I also sign my full name to anything I pen. Once again, I did not receive on thin dime for my OpEd, nor did anyone I have worked for in the past, or currently, have any input into my personal opinion. In fact, if Oginikwe thought for even one moment, s/he would realize what I penned would never have made it past industry screeners. I am all for changes in the use of antibiotics in feed animals, I just want an honest discussion and not the 80% crap that keeps getting the headlines.

        Tell us truthfully, Oginikwe and Mychajlonka_PhD, have you ever taken an ionophore or a tetracycline, meds that make up nearly 70% of all antibiotics sold for use in animals?

        Or have you ever had one of the very rare diseases the CU lists as illnesses that tetracyclines “are used” to treat, such as RMSF or Bubonic Plague? As always, they try to confuse the less informed readers with language such as this. “Are used” would be much honest and informative if they said “are rarely used as a very poor second choice for people who do not tolerate the drugs of choice, the macrolide class, to treat bubonic plague, lyme disease and RMSF”.  But using the proper descriptive would not help the scientists at CU advance their positions, would it?    

  • Oginikwe

    Consumer Reports: first, I read about the arsenic in rice and my hair stood on end, then came the pork story and I added CR to my favorites, now this excellent response.

    Consumer Reports is on FIRE lately!  Please keep up the good work; we need you to do what the FDA won’t!  ;-D

  • Mike_Mychajlonka_PhD

    I entirely agree with your sentiment that comments made on this (or any other) forum should come attached with the actual name of the author.  In my opinion, that also goes for the anonymous “likes” that this forum allows.  My problem with FSN’s current policy is the tendency of some to interpret the number of anonymous  “likes” as some sort of quantitative judgment as to the “quality” of a given comment.  I don’t see that at all.

     For my part, I don’t recall ever taking an ionophore.  In spite of that, the fact (as I have pointed out earlier) that selection for resistance to the ionophore Narasin also co-selects for Vancomycin resistance (to produce VRE) scares me, as well it should frighten any thinking person, given that Vancomycin, toxic as it is, is often a drug of last resort when faced with multiply antibiotic resistant pathogenic microbes.

    Tetracyclines are used to treat a wide variety of illnesses.  Some are relatively rare, as you point out.  Others are much more common (e.g., moderate or severe acne, stomach ulcers caused by Helicobacter pylori, etc.).  In any case, there are only two companies (Teva and Watson) that manufacture tetracyclines in the United States.  The most recent (1/9/2013) statement I have seen from the American Society of Health System Pharmacists states that neither company currently has any stock of this drug available for sale (for human use).  Neither company is able to predict when more salable stock will be available.  Both CDC and FDA have expressed concern about the tetracycline shortage, not a reaction you might expect on behalf of an antibiotic family unimportant to humans.  Furthermore, the tetracycline family is not just used for animals (humans or their food animals).  For example, in 1997 26,700 lbs. of oxytetracycline were applied to fruit trees here in the U.S.  Such usage has been going on for the past quarter of a century.  This antibiotic (along with streptomycin) is used to treat various plant diseases.  Fruit growers are worried that widespread resistance to the tetracycline family of antibiotics may significantly reduce their incomes because their line of defense against certain blights will have been made moot by the onset of antibiotic resistance.  Are we supposed to have a battle between fruit growers and cattlemen?

    I am glad to hear that you are ” . . . all for changes in the use of antibiotics in feed animals.”  Such changes are called for.  My disagreement with your position is my belief that such changes need not hurt the meat industry as a whole.  Having said that, however, I also think that producers able to stay ahead of the curve on the antibiotics-as-growth-promoters issue are likely to take over market share from those more prone to looking backward.